ID   CD209_MACMU             Reviewed;         404 AA.
AC   Q95J96; Q8HXL6; Q8HXL7; Q8HXL8; Q8HXL9; Q8SQB2; Q95LA8;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   13-APR-2004, sequence version 2.
DT   03-AUG-2022, entry version 105.
DE   RecName: Full=CD209 antigen;
DE   AltName: Full=Dendritic cell-specific ICAM-3-grabbing non-integrin 1;
DE            Short=DC-SIGN1;
DE   AltName: CD_antigen=CD209;
GN   Name=CD209;
OS   Macaca mulatta (Rhesus macaque).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini;
OC   Cercopithecidae; Cercopithecinae; Macaca.
OX   NCBI_TaxID=9544;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 1), TISSUE SPECIFICITY, AND INTERACTION WITH
RP   ICAM2; ICAM3 AND HIV-1 GP120.
RC   TISSUE=Lymph node;
RX   PubMed=11595296; DOI=10.1016/s0165-2478(01)00279-6;
RA   Geijtenbeek T.B.H., Koopman G., van Duijnhoven G.C.F., van Vliet S.J.,
RA   van Schijndel A.C.H.W., Engering A., Heeney J.L., van Kooyk Y.;
RT   "Rhesus and chimpanzee DC-SIGN act as HIV/SIV gp120 trans-receptors,
RT   similar as human DC-SIGN.";
RL   Immunol. Lett. 79:101-107(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 2), AND INTERACTION WITH HIV-1; HIV-2; SIV AND
RP   ICAM3.
RX   PubMed=11581396; DOI=10.1128/jvi.75.21.10281-10289.2001;
RA   Baribaud F., Pohlmann S., Sparwasser T., Kimata M.T., Choi Y.K.,
RA   Haggarty B.S., Ahmad N., Macfarlan T., Edwards T.G., Leslie G.J.,
RA   Arnason J., Reinhart T.A., Kimata J.T., Littman D.R., Hoxie J.A.,
RA   Doms R.W.;
RT   "Functional and antigenic characterization of human, rhesus macaque,
RT   pigtailed macaque, and murine DC-SIGN.";
RL   J. Virol. 75:10281-10289(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND INTERACTION WITH HIV-1 AND SIV.
RX   PubMed=11818554; DOI=10.1073/pnas.032654399;
RA   Wu L., Bashirova A.A., Martin T.D., Villamide L., Mehlhop E., Chertov A.O.,
RA   Unutmaz D., Pope M., Carrington M., Kewalramani V.N.;
RT   "Rhesus macaque dendritic cells efficiently transmit primate lentiviruses
RT   independently of DC-SIGN.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:1568-1573(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 2; 3; 4 AND 5).
RX   PubMed=12230940; DOI=10.1089/088922202760265641;
RA   Santos P.R., Petitprez K., Butor C.;
RT   "Gene for Chinese rhesus macaque DC-SIGN predicts the existence of A but
RT   not B isoforms of the protein.";
RL   AIDS Res. Hum. Retroviruses 18:977-981(2002).
CC   -!- FUNCTION: Pathogen-recognition receptor expressed on the surface of
CC       immature dendritic cells (DCs) and involved in initiation of primary
CC       immune response. Thought to mediate the endocytosis of pathogens which
CC       are subsequently degraded in lysosomal compartments. The receptor
CC       returns to the cell membrane surface and the pathogen-derived antigens
CC       are presented to resting T-cells via MHC class II proteins to initiate
CC       the adaptive immune response. Probably recognizes in a calcium-
CC       dependent manner high mannose N-linked oligosaccharides in a variety of
CC       pathogen antigens (By similarity). {ECO:0000250}.
CC   -!- FUNCTION: On DCs it is a high affinity receptor for ICAM2 and ICAM3 by
CC       binding to mannose-like carbohydrates. May act as a DC rolling receptor
CC       that mediates transendothelial migration of DC presursors from blood to
CC       tissues by binding endothelial ICAM2. Seems to regulate DC-induced T-
CC       cell proliferation by binding to ICAM3 on T-cells in the immunological
CC       synapse formed between DC and T-cells (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homotetramer. Interacts with C1QBP; the interaction is
CC       indicative for a C1q:C1QBP:CD209 signaling complex. Interacts with
CC       ICAM2 and ICAM3 by binding to mannose-like carbohydrates. Interacts
CC       (via C-type lectin domain) with CEACAM1 (via Lewis X moieties); this
CC       interaction is regulated by the glycosylation pattern of CEACAM1 on
CC       cell types and regulates contact between dendritic cells and
CC       neutrophils. {ECO:0000250|UniProtKB:Q9NNX6}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type II
CC       membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q95J96-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q95J96-2; Sequence=VSP_010053;
CC       Name=3;
CC         IsoId=Q95J96-3; Sequence=VSP_010053, VSP_010054;
CC       Name=4;
CC         IsoId=Q95J96-4; Sequence=VSP_010052;
CC       Name=5;
CC         IsoId=Q95J96-5; Sequence=VSP_010051;
CC   -!- MISCELLANEOUS: In vitro, is a receptor for HIV-1, HIV-2 and SIV and
CC       transmits viruses to permissive T-cells.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF391086; AAK97459.1; -; mRNA.
DR   EMBL; AF369755; AAL14438.1; -; mRNA.
DR   EMBL; AY040319; AAK74185.1; -; mRNA.
DR   EMBL; AJ439425; CAD28396.1; -; Genomic_DNA.
DR   EMBL; AJ439425; CAD28397.1; -; Genomic_DNA.
DR   EMBL; AJ439425; CAD28398.1; -; Genomic_DNA.
DR   EMBL; AJ439425; CAD28399.1; -; Genomic_DNA.
DR   RefSeq; NP_001028042.1; NM_001032870.1.
DR   RefSeq; NP_001028261.1; NM_001033089.1.
DR   AlphaFoldDB; Q95J96; -.
DR   SMR; Q95J96; -.
DR   STRING; 9544.ENSMMUP00000029556; -.
DR   GeneID; 574211; -.
DR   KEGG; mcc:574211; -.
DR   CTD; 30835; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   InParanoid; Q95J96; -.
DR   OrthoDB; 1232767at2759; -.
DR   Proteomes; UP000006718; Unplaced.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030246; F:carbohydrate binding; IBA:GO_Central.
DR   GO; GO:0005537; F:mannose binding; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   CDD; cd03590; CLECT_DC-SIGN_like; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR033989; CD209-like_CTLD.
DR   InterPro; IPR016187; CTDL_fold.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   Adaptive immunity; Alternative splicing; Calcium; Cell adhesion;
KW   Disulfide bond; Endocytosis; Glycoprotein; Immunity; Innate immunity;
KW   Lectin; Mannose-binding; Membrane; Metal-binding; Receptor;
KW   Reference proteome; Repeat; Signal-anchor; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..404
FT                   /note="CD209 antigen"
FT                   /id="PRO_0000046599"
FT   TOPO_DOM        1..37
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        38..58
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        59..404
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   REPEAT          96..118
FT                   /note="1"
FT   REPEAT          119..141
FT                   /note="2"
FT   REPEAT          142..164
FT                   /note="3"
FT   REPEAT          165..187
FT                   /note="4"
FT   REPEAT          188..210
FT                   /note="5"
FT   REPEAT          211..233
FT                   /note="6"
FT   REPEAT          234..257
FT                   /note="7"
FT   DOMAIN          263..378
FT                   /note="C-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   REGION          96..257
FT                   /note="7 X approximate tandem repeats"
FT   REGION          382..404
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           14..15
FT                   /note="Endocytosis signal"
FT                   /evidence="ECO:0000250"
FT   MOTIF           16..18
FT                   /note="Endocytosis signal"
FT                   /evidence="ECO:0000255"
FT   MOTIF           31..34
FT                   /note="Endocytosis signal"
FT                   /evidence="ECO:0000255"
FT   BINDING         347
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         349
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         351
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         354
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         365
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         366
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        80
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        256..267
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DISULFID        284..377
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DISULFID        356..369
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   VAR_SEQ         74..308
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_010051"
FT   VAR_SEQ         143..235
FT                   /note="LQEIYQELTRLKAAVGELPEKSKMQEIYQELSRLKAAVGDLPEKSKQQEIYQ
FT                   ELSRLKAAVGDLPEKSKQQEIYQKLTQLKAAVDGLPDRSKQ -> L (in isoform
FT                   4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_010052"
FT   VAR_SEQ         165..187
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11818554"
FT                   /id="VSP_010053"
FT   VAR_SEQ         301..306
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_010054"
FT   CONFLICT        13
FT                   /note="D -> G (in Ref. 2 and 3)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        112
FT                   /note="G -> D (in Ref. 1; AAK97459)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        152
FT                   /note="R -> W (in Ref. 1; AAK97459)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        197
FT                   /note="S -> T (in Ref. 1; AAK97459)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        205
FT                   /note="D -> E (in Ref. 4; CAD28397/CAD28398)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        254
FT                   /note="H -> R (in Ref. 2 and 3)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        279
FT                   /note="D -> N (in Ref. 2 and 3)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        404
FT                   /note="A -> E (in Ref. 3; AAK74185)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   404 AA;  45554 MW;  E4C5D69FA7FCDB70 CRC64;
     MSDSKEPRLQ QLDLLEEEQL GGVGFRQTRG YKSLAGCLGH GPLVLQLLSF TLLAGLLVQV
     SKVPSSLSQG QSKQDAIYQN LTQLKVAVSE LSEKSKQQEI YQELTRLKAA VGELPEKSKQ
     QEIYEELTRL KAAVGELPEK SKLQEIYQEL TRLKAAVGEL PEKSKMQEIY QELSRLKAAV
     GDLPEKSKQQ EIYQELSRLK AAVGDLPEKS KQQEIYQKLT QLKAAVDGLP DRSKQQEIYQ
     ELIQLKAAVE RLCHPCPWEW TFFQGNCYFM SNSQRNWHDS ITACQEVGAQ LVVIKSAEEQ
     NFLQLQSSRS NRFTWMGLSD LNHEGTWQWV DGSPLLPSFK QYWNKGEPNN IGEEDCAEFS
     GNGWNDDKCN LAKFWICKKS AASCSGDEER LLSPAPTTPN PPPA
//
